A prospective interventional randomized controlled trial to assess the effect of low dose acetylsalicylic acid as a preventive treatment of preeclampsia in pregnant women who underwent frozen embryo transfer

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516816-72-00

Enrollment

276

Registered

2024-09-12

Start date

2022-04-27

Completion date

Unknown

Last updated

2024-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preeclampsia

Brief summary

Mean number of women suffering from preeclampsia in the treated and not treated groups.

Interventions

DRUGAsaflow 80 mg

DRUGmaagsapresistente tabletten

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
Mean number of women suffering from preeclampsia in the treated and not treated groups.	—

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026